These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3884243)

  • 1. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism.
    Dezfulian M; Hatheway CL; Yolken RH; Bartlett JG
    J Clin Microbiol; 1984 Sep; 20(3):379-83. PubMed ID: 6490825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism.
    Dowell VR; McCroskey LM; Hatheway CL; Lombard GL; Hughes JM; Merson MH
    JAMA; 1977 Oct; 238(17):1829-32. PubMed ID: 333132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism.
    Paton JC; Lawrence AJ; Steven IM
    J Clin Microbiol; 1983 Jan; 17(1):13-5. PubMed ID: 6338033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of Clostridium botulinum organisms and toxin in the feces of an infant with botulism.
    Paton JC; Lawrence AJ; Manson JI
    J Clin Microbiol; 1982 Jan; 15(1):1-4. PubMed ID: 6764763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Clostridium difficile toxin from Clostridium botulinum toxin by the mouse lethality test.
    Gilligan PH; Brown L; Berman RE
    Appl Environ Microbiol; 1983 Jan; 45(1):347-9. PubMed ID: 6824325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective isolation and rapid identification of Clostridium botulinum types A and B by toxin detection.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1985 Feb; 21(2):231-3. PubMed ID: 3882748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory aspects of infant botulism in California.
    Midura TF
    Rev Infect Dis; 1979; 1(4):652-5. PubMed ID: 399372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of feces and serum for diagnosis of infant botulism in 336 patients.
    Hatheway CL; McCroskey LM
    J Clin Microbiol; 1987 Dec; 25(12):2334-8. PubMed ID: 3323228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A.
    Notermans S; Dufrenne J; Schothorst M
    Jpn J Med Sci Biol; 1978 Feb; 31(1):81-5. PubMed ID: 351243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibodies in enzyme linked immunosorbent assay (ELISA) for detection of botulinum type B toxins.
    Notermans S; Kozaki S; Kamata Y; Sakaguchi G
    Jpn J Med Sci Biol; 1984 Jun; 37(3):137-40. PubMed ID: 6389944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient. A method for selectively removing interfering substances from clinical specimens.
    Horwitz MA; Hatheway CL; Dowell VR
    Am J Clin Pathol; 1976 Oct; 66(4):737-42. PubMed ID: 970375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical toxin variant of Clostridium botulinum type B associated with infant botulism.
    Hatheway CL; McCroskey LM; Lombard GL; Dowell VR
    J Clin Microbiol; 1981 Dec; 14(6):607-11. PubMed ID: 7037830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Clostridium botulinum type A toxin and organisms in the feces of a case of infant botulism and examination of other related specimens.
    Takahashi M; Shimizu T; Ooi K; Noda H; Nasu T; Sakaguchi G
    Jpn J Med Sci Biol; 1988 Feb; 41(1):21-6. PubMed ID: 3057266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin.
    Notermans S; Dufrenne J; Kozaki S
    Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-linked immunosorbent assay (ELISA) for the detection and differentiation of Clostridium botulinum toxins type A and B.
    Michalik M; Grzybowski J; Ligieza J; Reiss J
    J Immunol Methods; 1986 Nov; 93(2):225-30. PubMed ID: 3095433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.